May 3 2019 - FDA approves AstraZeneca’s type 2 diabetes therapy

May 3 2019 - FDA approves AstraZeneca’s type 2 diabetes therapy

FDA approves AstraZeneca’s type 2 diabetes therapy
Celgene reports durable responses to multiple myeloma CAR-T
Amgen and Syapse in precision medicine collaboration in oncology
GSK Trelegy clinical trial could unlock asthma indication
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*

NEW board: ASK A WHISTLEBLOWER ATTORNEY
Today's most popular searches:

image: